The Disorder That Supposedly Didn't Exist Until Yesterday
Everyone has heard the argument, and many people quietly believe some version of it. ADHD is what we now call childhood. It's a diagnosis manufactured to explain boys who won't sit down, or to excuse adults who won't finish anything, or to sell stimulants to a distracted generation. It's the predictable result of feeding children sugar, handing them phones, and asking them to sit still for six hours a day in rooms designed a century ago. Strip away the medical language, the argument goes, and what's left is an ordinary human range that we have decided to pathologise.
It is a reasonable-sounding story. It has one problem, and the problem is chronological.
ADHD reads like a modern epidemic — a disorder supposedly invented by smartphones, sugar, and a culture that can't sit still — but the same restless, inattentive mind was described in a German medical textbook in 1775, a full century before the lightbulb: the name kept changing, the mind never did.
That is the thread this article follows. Not a list of dates, but a story with an argument buried in it: physicians in powdered wigs, writing by candlelight, in societies with no screens and no processed food and no standardised testing, kept noticing the same specific pattern of people. They described it carefully. They gave it names. Then medicine forgot, rediscovered, renamed, and re-forgot it, over and over, for two hundred and fifty years. Same mind, new name.
1775–1798: The First Descriptions, Before There Was a Name
In 1775, a German physician named Melchior Adam Weikard published a textbook called Der Philosophische Arzt — The Philosophical Physician. In it he gave a chapter to a condition he called Mangel der Aufmerksamkeit, lack of attention, which he also rendered in Latin as Attentio Volubilis. The chapter is a description of people whose attention will not hold still. Weikard's own summary, in the translation Russell Barkley and Helmut Peters produced when they located and translated the original text, is characteristically blunt: "An inattentive person won't remark anything but will be shallow everywhere" (Barkley & Peters, 2012).
Barkley and Peters argue that this deserves to be credited as the earliest known description of an attention disorder in the medical literature. It is worth sitting with the date. 1775. The American colonies had not yet declared independence. Electric light, mass compulsory schooling, refined-sugar diets, television, and the smartphone were each a century or more away. And a working physician thought this pattern of mind was distinct enough, common enough, and consequential enough to give it a chapter in a general medical textbook.
Twenty-three years later, in 1798, the Scottish physician Alexander Crichton published An Inquiry into the Nature and Origin of Mental Derangement, and described something recognisably the same. Crichton wrote of "the incapacity of attending with a necessary degree of constancy to any one object," and observed that in such people the faculty of attention "is incessantly withdrawn from one impression to another" (Lange et al., 2010). This is not a description of laziness or defiance. It is a description of a mind whose attention is pulled away from its object against the person's intention — of people who could not hold focus even when they were plainly trying to.
Two physicians, two countries, two decades apart, both writing before the nineteenth century began, both describing the same restless and inattentive mind. Neither had a name for it that survived. What they had was the observation.
1902: George Still Puts It in Front of Medicine
The name most people encounter first, if they go looking for the history of ADHD, is George Frederic Still. In 1902 the English paediatrician delivered a series of lectures to the Royal College of Physicians of London, titled "On Some Abnormal Psychical Conditions in Children," in which he described children showing what he called "an abnormal defect of moral control" (Lange et al., 2010). The phrase grates on a modern ear, and it should be read in its period sense: Still was describing a failure of self-regulation — of the capacity to restrain impulse and sustain attention toward a chosen end — not delivering a verdict on these children's characters.
Still's lectures matter enormously, because they put the pattern in front of mainstream medicine in a form that could not be ignored, at an institution that conferred authority. He is, deservedly, part of every account of this history.
What he is not is first. Still is routinely described — in textbooks, in press coverage, in the opening paragraph of countless articles — as the first person to describe ADHD. Weikard preceded him by 127 years and Crichton by 104. That misattribution is itself a small piece of the story this article is telling: the record kept getting written over. Each generation of physicians met this mind, described it in its own vocabulary, and largely lost track of the fact that someone had already done so. Same mind, new name — and, often enough, no memory of the old one.
1937: The Accident in Providence
The next turn in this story was not a discovery. It was a mistake that happened to be productive.
At the Emma Pendleton Bradley Home in Providence, Rhode Island — a children's neuropsychiatric hospital that had opened in 1931 — a young physician named Charles Bradley was treating children who had undergone pneumoencephalography, a now-abandoned imaging procedure that involved draining cerebrospinal fluid and replacing it with air before X-raying the brain. It left patients with severe headaches. Bradley reasoned that a stimulant might help the body replace the lost fluid faster, and so relieve the pain. He gave the children Benzedrine, an amphetamine.
The headaches were unaffected. Something else happened entirely. Of the thirty children who received it, fourteen showed what Bradley described as a spectacular change in behaviour, along with remarkably improved school performance — children who had been unable to sit with a task were suddenly working through it (Strohl, 2011; Bradley, 1937). He published the observation in the American Journal of Psychiatry in 1937 under the plain title "The Behavior of Children Receiving Benzedrine."
And then, in one of the stranger silences in the history of medicine, essentially nothing happened. Bradley's finding went largely ignored in child psychiatry for close to twenty-five years (Strohl, 2011). One of the most consequential observations in twentieth-century psychiatry sat in the literature, published and available, while a generation of children who might have been helped by the understanding it implied grew up without it.
1950s–60s: Chemistry and a Clumsy Name
The chemistry arrived before the understanding did. Methylphenidate was first synthesised in 1944 by Leandro Panizzon, and marketed under the name Ritalin by the Ciba pharmaceutical company in 1954 (Lange et al., 2010). A compound that would become one of the most-discussed medicines of the following seventy years entered the world roughly a decade before the field had a stable name for what it treated, and while Bradley's finding was still sitting largely unread.
The name medicine settled on in the meantime was a monument to confusion. Through the middle of the century, children with this pattern were said to have minimal brain damage — the assumption being that some subtle injury, too small to find, must underlie the behaviour. The trouble was that no one could find it. In 1963 an international study group meeting in Oxford recommended dropping "damage" in favour of minimal brain dysfunction, on the straightforward grounds that "evidence of anatomical damage is usually absent" (Lange et al., 2010).
It is worth pausing on what that label meant to be called. A child was not inattentive; a child was minimally brain damaged, and then, after 1963, minimally brain dysfunctional — a term that named an absence of findings rather than a presence of anything. The mind under the label was the one Weikard had described in a chapter about attention. The label was a confession of ignorance wearing a clinical coat. Same mind, new name.
The DSM Renamings: Same Mind, New Name
From here the history becomes, in large part, the history of a book: the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders. Each edition renamed the condition, and each renaming reveals what its authors thought was central to it.
In 1968, the DSM-II gave it a name built entirely around movement: Hyperkinetic Reaction of Childhood, characterised by "overactivity, restlessness, distractibility, and short attention span" (Lange et al., 2010). The visible child — the one who would not stay in the chair — defined the category. The invisible child, the quiet one whose attention drifted out the window, barely registered.
In 1980, the DSM-III performed the single most important conceptual correction in this history. It renamed the condition Attention Deficit Disorder (ADD), with or without hyperactivity (Lange et al., 2010). Attention moved from the periphery to the centre of the definition, and hyperactivity was demoted to an optional feature. Two hundred and five years after Weikard gave his chapter the title lack of attention, the manual agreed with him.
In 1987, the DSM-III-R produced the name still in use today: Attention Deficit Hyperactivity Disorder (Lange et al., 2010). And in 2013, the DSM-5 made changes that mattered more than a name. It raised the age-of-onset criterion from 7 to 12, lowered the symptom threshold to five for people aged 17 and older, and added fuller descriptions of how the condition presents in adolescents and adults (American Psychiatric Association, DSM-5, 2013).
Line those up and read them as a sequence. Hyperkinetic Reaction of Childhood. Attention Deficit Disorder. Attention Deficit Hyperactivity Disorder. Three names in nineteen years, from a profession describing the same children. What changed across those revisions was not the children. It was which part of them medicine happened to be looking at: first the moving body, then the wandering attention, then both together. Same mind, new name — the phrase is nearly a summary of the entire twentieth century on this subject.
This is also the reason so many people were missed. A diagnostic system organised around visible overactivity will find the children who move and overlook the ones who drift, which is a large part of why girls and women went uncounted for decades, and why so many adults arrive at a diagnosis thirty years late. The name determined who got seen.
From Childhood Problem to Lifelong Condition
Every name in the previous section, until 2013, contained or assumed the word childhood. The condition was understood as something that happened to children and that children then grew out of. The last few decades have dismantled that assumption.
The clearest statement of where the science currently stands is the World Federation of ADHD International Consensus Statement, published in 2021 by Stephen Faraone and a large group of collaborators, which distilled the evidence into 208 empirically supported statements about the disorder (Faraone et al., 2021). Two of its conclusions close the arc this article has traced.
The first is that ADHD does not reliably end with childhood. In adolescence and young adulthood, the consensus states, many individuals with a history of childhood ADHD continue to be impaired by the disorder; by age twenty-five, about half show signs of residual impairment. The second concerns where it comes from. Reviewing thirty-seven twin studies conducted across the United States, Europe, Scandinavia, and Australia, the consensus concludes that genes and their interaction with the environment must play a substantial role in causing ADHD — which is to say that this is a condition that runs in families and is written, in part, into inheritance. That genetic story has its own considerable depth, taken up in our article on whether ADHD is genetic.
So the mind that Weikard described in a chapter on attention, that Crichton watched being pulled from one impression to another, that Still presented to the Royal College, that Bradley stumbled into treating, and that the DSM renamed three times in nineteen years, turns out to be substantially heritable and to persist, for many people, across an entire life. It was never a childhood phase. It was never a modern invention. It was a durable, inheritable way of having a brain, being described in the vocabulary each century happened to own.
Why the History Matters (and What It Doesn't Settle)
Return to the argument that opened this article — that ADHD is a modern artefact, produced by screens and sugar and a culture that stopped expecting anyone to sit still. Set it against the timeline. Weikard, 1775, writing about people who could not hold their attention. Crichton, 1798, describing attention withdrawn "incessantly from one impression to another." Still, 1902, lecturing the Royal College. Bradley, 1937, watching thirty children in Providence. Every one of them predates television. Weikard and Crichton predate the lightbulb, the railway, and compulsory schooling.
The sugar claim can be tested more directly still, and it has been. The 2021 consensus statement cites a meta-analysis of seven studies covering more than twenty-five thousand participants, drawn from six countries across three continents, which found no evidence of an association between sugar consumption and ADHD in young people (Faraone et al., 2021). The most confidently repeated folk explanation for ADHD has been examined at scale and did not survive.
This is the quiet argument the timeline makes on behalf of anyone who has been told they are simply undisciplined. These minds were here in 1775. They were here in a world with nothing to blame. Physicians who had every cultural incentive to call this a moral failing looked closely and concluded, instead, that it was a condition of attention worth describing in a medical text. Whatever else is true, the pattern is not an artefact of the century you happen to live in. It is older than the things you have been told caused it.
But a timeline can be pushed further than it can bear, and it is worth being precise about its limits. A history proves these minds were always here and always struggled; it does not diagnose you — and being describable in 1775 is not the same as being understood in 2026, because the science is still moving and still argues with itself.
All of the following remain genuinely contested, or genuinely open: how ADHD should be bounded against conditions that resemble it, how much of the recent rise in diagnoses reflects better recognition versus over-diagnosis, how the criteria should handle adults who were never assessed as children, and what the underlying mechanisms actually are. The distinction from look-alike conditions in particular is difficult enough that the conditions mistaken for ADHD, and vice versa require an article of their own. Recognising yourself in an eighteenth-century description is a reason to take the question seriously and bring it to someone qualified to answer it. It is not an answer.
What the history does settle is narrower, and still worth having. The pattern is old. The people were real. The names were ours. Same mind, new name — and whatever the next revision decides to call it, the mind will still be the one Weikard sat down to describe in 1775.
Where Zalfol Fits
Two hundred and fifty years of physicians noticed the same difficulty and, understandably, spent most of that time trying to correct the person. The tools these minds were handed — the schoolroom, the timetable, the ledger, and eventually the productivity app — were built by and for a different kind of attention, and then offered to this one as though the failure to use them well were a failure of will. Zalfol starts from the opposite premise. The mind in the timeline is not broken. The tools were simply never designed for it.
Four of Zalfol's spaces are built directly for the mind this article has been describing:
- CEO Mode — the strategic layer, where a month's work is defined and broken into outcomes. It supplies from the outside the planning structure the timeline keeps describing as hard to hold from the inside: what matters, what is next, what done actually looks like.
- Goldfish Mode — one task, full screen, nothing else on it. Total isolation for the attention that every era named differently and every era found difficult to sustain, from Weikard's Mangel der Aufmerksamkeit to the DSM's attention deficit.
- Miner Mode — a place to capture the racing, associative thought that predates every label the manuals invented for it. No structure, no prompts, no labels: just somewhere for the mind Crichton described, moving incessantly from one impression to another, to put what it finds there.
- Dump — a full flush of working memory onto the page, for the restless mind Weikard would have recognised on sight. Everything out of the head first; sorting comes after.
None of this is treatment, and the boundary deserves to be stated rather than implied. Zalfol is a cognitive tool, not a medical treatment. It cannot diagnose you, it does not replace a clinician, and it settles none of the open questions above. What it can do is stop asking a two-hundred-and-fifty-year-old pattern of attention to behave like something it has never once, in the entire written record, behaved like. Zalfol works with the wiring. Not against it.
Frequently Asked Questions
Sources
- Lange, K. W., Reichl, S., Lange, K. M., Tucha, L., & Tucha, O. (2010). The history of attention deficit hyperactivity disorder. ADHD Attention Deficit and Hyperactivity Disorders, 2(4), 241–255. PMC3000907
- Barkley, R. A., & Peters, H. (2012). The earliest reference to ADHD in the medical literature? Melchior Adam Weikard's description in 1775 of "attention deficit" (Mangel der Aufmerksamkeit, Attentio Volubilis). Journal of Attention Disorders, 16(8), 623–630. doi:10.1177/1087054711432309
- Strohl, M. P. (2011). Bradley's Benzedrine studies on children with behavioral disorders. Yale Journal of Biology and Medicine, 84(1), 27–33. PMC3064242
- Bradley, C. (1937). The behavior of children receiving Benzedrine. American Journal of Psychiatry, 94(3), 577. doi:10.1176/ajp.94.3.577
- Faraone, S. V., Banaschewski, T., Coghill, D., et al. (2021). The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews, 128, 789–818. PMC8328933
- American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Washington, DC: American Psychiatric Publishing. DSM-5 — for the age-of-onset change from 7 to 12, the five-symptom threshold at age 17 and older, and the expanded adolescent and adult descriptions.